Literature DB >> 157148

Relationship between hypertension and angina pectoris.

P J Richardson, L S Hill.   

Abstract

1 Many factors are of importance in the relationship between angina pectoris and hypertensive heart disease. Vascular resistance modifies the oxygen supply, whereas the oxygen demand is influenced by the systolic and diastolic BPs, the diastolic filling time and wall tension, the duration of systole and transmural pressure and the sympathetic stimulation to the heart. 2 The treatment of angina pectoris in patients with hypertensive heart disease should aim to reduce myocardial ischaemia, and it is suggested that beta-adrenoceptor antagonists are most suitable, as they reduce BP, heart rate and myocardial contractility and thus oxygen demand.

Entities:  

Mesh:

Year:  1979        PMID: 157148      PMCID: PMC1429315          DOI: 10.1111/j.1365-2125.1979.tb04697.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Susceptibility to coronary heart disease.

Authors:  T R DAWBER; W B KANNEL
Journal:  Mod Concepts Cardiovasc Dis       Date:  1961-07

Review 2.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

3.  The myocardium in hyperfunction, hypertrophy and heart failure.

Authors:  F Z Meerson
Journal:  Circ Res       Date:  1969-07       Impact factor: 17.367

4.  Regression of left ventricular hypertrophy during treatment with antihypertensive agents.

Authors:  L S Hill; M Monaghan; P J Richardson
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Echocardiographic classification of hypertensive heart disease. A correlative study with clinical features.

Authors:  H Toshima; Y Koga; H Yoshioka; T Akiyoshi; N Kimura
Journal:  Jpn Heart J       Date:  1975-07

6.  Circulating catecholamine levels in human and experimental hypertension.

Authors:  J de Champlain; L Farley; D Cousineau; M R van Ameringen
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

7.  Left ventricular performance in patients with left ventricular hypertrophy caused by systemic arterial hypertension.

Authors:  J S Karlinger; D Williams; J Gorwit; M H Crawford; R A O'Rourke
Journal:  Br Heart J       Date:  1977-11

8.  Cardiac hypertrophy and antihypertensive therapy.

Authors:  S Sen; R C Tarazi; F M Bumpus
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

9.  Coronary heart-disease after treatment of hypertension.

Authors:  G Berglund; R Sannerstedt; O Andersson; H Wedel; L Wilhelmsen; L Hansson; R Sivertsson; J Wikstrand
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

Review 10.  Role of hypertension in atherosclerosis and cardiovascular disease.

Authors:  W Hollander
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

View more
  3 in total

1.  Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.

Authors:  L H Opie; D White; J Lee; W F Lubbe
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 2.  Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

3.  Reactive Oxygen Species Cause Exercise-Induced Angina in a Myocardial Ischaemia-Reperfusion Injury Model.

Authors:  Xiaohang Wang; Hirosato Kanda; Takeshi Tsujino; Yoko Kogure; Feng Zhu; Satoshi Yamamoto; Taichi Sakaguchi; Koichi Noguchi; Yi Dai
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.